Dr. Janio Szklaruk, MD, PHD
Claim this profileMore about Janio Szklaruk, MD, PHD
Clinical Trial Related
11 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Janio Szklaruk, MD, PHD has experience with
- Gadobutrol
- Gadoxetate Disodium
Breakdown of trials Janio Szklaruk, MD, PHD has run
Congenital Hepatobiliary Disorders
Liver Cancer
Hepatobiliary disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Janio Szklaruk, MD, PHD specialize in?
Janio Szklaruk, MD, PHD focuses on Congenital Hepatobiliary Disorders and Liver Cancer. In particular, much of their work with Congenital Hepatobiliary Disorders has involved treating patients, or patients who are undergoing treatment.
Is Janio Szklaruk, MD, PHD currently recruiting for clinical trials?
No, Janio Szklaruk, MD, PHD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Janio Szklaruk, MD, PHD has studied deeply?
Yes, Janio Szklaruk, MD, PHD has studied treatments such as Gadobutrol, Gadoxetate Disodium.
What is the best way to schedule an appointment with Janio Szklaruk, MD, PHD?
Apply for one of the trials that Janio Szklaruk, MD, PHD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.